Homepage
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
On-Demand Webinar: Rare Disease Therapeutics
Learn about important trends in rare disease therapeutics and approaches for accelerating the drug discovery and development process
Publication: DNA-Compatible Cyclization Reaction
Learn about new methods to form 1,3,4-oxadiazoles and 1,2,4-triazoles, as superior starting points for the development of bioavailable drugs
Poster: EGFR TKI-Resistant Tumor Models
Learn about the development of drug-resistant models tailored to distinct EGFR inhibitor resistance mechanisms for use in targeted therapeutic approaches
White Paper: Drug Discovery Strategies for Targeted Protein Degradation
Learn how how DNA-encoded library (DEL) technology can be used for the direct discovery of proteolysis-targeting chimeras
Spotlight on Services: High-Dimensional Flow Cytometry
Learn how high-dimensional flow cytometry allows researchers to perform deep phenotyping of immune cells at the single cell level with increased accuracy
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Our world-class discovery platform is backed by nearly 3000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules, oligonucleotides, and peptides to antibodies, cell, and gene therapies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Covalent Warhead and DEL-Generated Hit Fragmentation
VIEW PosterLatest Poster
Establishment of EGFR TKI-Resistant Tumor Models
Establishment of EGFR TKI-Resistant Tumor Models
VIEW PosterLatest Publication
iMN041: Prodrug with a Unique Antitumor Immune Response
iMN041: Prodrug with a Unique Antitumor Immune Response
VIEW PublicationLatest Publication
DNA-Compatible Cyclizations
DNA-Compatible Cyclizations to Form Oxadiazoles and Triazoles
VIEW PublicationLatest Presentation
EML4-ALK Cell Lines and In Vivo Models
EML4-ALK Cell Lines and In Vivo Models
VIEW PresentationLatest Presentation
High-Dimensional Flow Cytometry Platform
High-dimensional flow cytometry services
VIEW Presentation